NCT01828008 Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas Status UNKNOWN Phase N/A
NCT01525394 A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval Status COMPLETED Phase PHASE1
NCT01512758 A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT01490047 Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas Status WITHDRAWN Phase PHASE1
NCT01387841 Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting Status COMPLETED Phase PHASE2
NCT01359982 Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects Status COMPLETED Phase PHASE1
NCT01273155 Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction Status COMPLETED Phase PHASE1
NCT01237236 A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. Status COMPLETED Phase PHASE1
NCT01200017 Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant Status NO_LONGER_AVAILABLE Phase N/A
NCT01194193 Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours Status WITHDRAWN Phase PHASE1
NCT01031641 Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability Testing Status COMPLETED Phase N/A
NCT00947739 Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00796562 Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy Status COMPLETED Phase PHASE2
NCT00788099 Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Status COMPLETED Phase PHASE1
NCT00725634 A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma Status COMPLETED Phase PHASE1